Idorsia's once-daily TRYVIO (aprocitentan) is now available in the U.S., advancing treatment options for millions of patients with difficult-to-control hypertension | Morningstar

Idorsia's once-daily TRYVIO (aprocitentan) is now available in the U.S., advancing treatment options for millions of patients with difficult-to-control hypertension Idorsia's once-daily TRYVIO (aprocitentan) is now available in the U.S.,
Read more...